Pulmonary emphysema
MONDO:0004849A subcategory of chronic obstructive pulmonary disease (COPD). It occurs in people who smoke and suffer from chronic bronchitis. It is characterized by inflation of the alveoli, alveolar wall damage, and reduction in the number of alveoli, resulting in difficulty breathing.
Also known as: emphysema, emphysema, pulmonary
77 clinical trials for this condition and its sub-types, 62 tagged with Pulmonary emphysema itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Pulmonary emphysema
-
Congenital lobar emphysema 2 trials
-
Compensatory emphysema 0 trials
-
Emphysema, hereditary pulmonary 0 trials
-
Hyperlucent lung 0 trials
-
Interstitial emphysema 0 trials
-
Can a new injection ease COPD and cut Flare-Ups?
Disease control Not yet recruitingThis trial is testing an investigational drug called brenipatide in adults with moderate-to-severe COPD. Participants will receive either brenipatide or a placebo for about a year, alongside standard care. The goal is to see if brenipatide improves lung function and reduces the n…
Phase 2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Surgical fix for failed lung valve treatment shows promise in early trial
Disease control Not yet recruitingThis trial investigates a surgical procedure to divide the fissure between lung lobes in people with COPD and emphysema who did not improve after endobronchial valve treatment. The goal is to see if the surgery is safe and feasible, potentially leading to better lung collapse and…
Sponsor: Rocco Bilancia • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Can a higher dose slow lung damage in Alpha-1 patients?
Disease control Not yet recruitingThis study tests whether higher doses of the drug Respreeza/Zemaira can slow lung damage better than the standard dose in adults with emphysema caused by Alpha-1 antitrypsin deficiency. About 270 participants will receive weekly IV infusions for 3 years. The goal is to find the o…
Phase 4 • Sponsor: CSL Behring • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New scan could boost success of lung valve treatment for emphysema
Disease control Not yet recruitingThis study tests whether a special scan (VQDI) can help doctors pick the best lung area to place tiny valves for severe emphysema. About 285 participants will be randomly assigned to have valve placement guided by either the new scan or the usual CT scan. The goal is to see if th…
Sponsor: China-Japan Friendship Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New exercise trick boosts strength in lung disease patients
Symptom relief Not yet recruitingThis study tests whether adding a blood flow restriction cuff to aerobic exercise helps people with emphysema or COPD build muscle and improve daily function. Sixty participants will either do standard aerobic exercise or the same exercise with the cuff. The goal is to see if thi…
Sponsor: Al-Zaytoonah University of Jordan • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Gene mutation linked to unexplained emphysema?
Knowledge-focused Not yet recruitingThis study aims to find out how often people with FLNA gene mutations develop emphysema, a type of lung disease. Researchers will use chest CT scans, blood tests, and lung function tests in 70 participants. The goal is to confirm if FLNA changes are a cause of unexplained emphyse…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC